Catalyst Pharmaceutical Partners to keep development of CPP-109 drug Catalyst Pharmaceutical Partners, Inc cialisprix.net . today announced that the business will continue steadily to develop CPP-109 for the treatment of cocaine and methamphetamine addiction. The Company’s decision was produced after, and based on, an in-depth overview of the results obtained from its 186-patient Phase II scientific trial evaluating the use of CPP-109 for the treatment of cocaine addiction and the top-line outcomes obtained from its 57-patient proof-of-concept research evaluating the use of CPP-109 for the treatment of methamphetamine addiction .
Catholic Charities USA releases statement in response to passing of Child Nutrition Bill Catholic Charities USA, the 100-year-old sociable service network focused on reducing poverty and strengthening families, today released the following statement in response to the passage of the Child Nutrition Expenses by the US Senate: While Catholic Charities USA strongly supports improved funding for improvements to Child Nutrition Programs, we are against cutting funds from the Supplemental Nutrition Assistance Plan to pay for these new investments. As one of the nation’s largest systems of social service providers, we just can’t pit one system that serves the indegent and vulnerable against another system that acts the same inhabitants.